Literature DB >> 12811553

Virilising adrenocortical tumours in children.

Walter Bonfig1, Iris Bittmann, Susanne Bechtold, Birgit Kammer, Vera Noelle, Sissi Arleth, Klemens Raile, Hans-Peter Schwarz.   

Abstract

UNLABELLED: Adrenocortical tumours (ACT) are a rare but important cause of virilisation in infancy and childhood. Four cases of virilising ACT are presented. Two girls (age 0.9 years and 3.9 years) and two boys (age 6.2 years and 6.4 years) had symptoms and signs of virilisation before the age of 6 years. Diagnosis of a virilising adrenal tumour was confirmed by laboratory tests, diagnostic imaging and histology. However, one female patient was misdiagnosed and treated for 3 months as atypical congenital adrenal hyperplasia. Ultrasonography of the adrenal region could not visualise the tumour in three out of four cases. The most sensitive method of diagnostic imaging was MRI. In all cases, treatment consisted of complete surgical resection of the adrenal tumour by open abdominal surgery. Immunohistochemistry was performed in all patients and in two patients there was an overexpression of p53, indicating p53 mutation and in three cases the ki67 proliferation index was greater than 5%. The classification of ACT in childhood is extremely difficult. Histology scores adapted from adrenal tumours in adults and molecular markers are under investigation, but there is still not enough clinical experience since ACT are so rare.
CONCLUSION: Long-term follow-up is mandatory not only because of the uncertainty in classification of adrenocortical tumours, but also for observation of growth and pubertal development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811553     DOI: 10.1007/s00431-003-1230-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

1.  Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

Authors:  A Prader; R H Largo; L Molinari; C Issler
Journal:  Helv Paediatr Acta Suppl       Date:  1989-06

Review 2.  Virilizing adrenocortical tumors in childhood: eight cases and a review of the literature.

Authors:  P D Lee; R J Winter; O C Green
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

3.  Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data.

Authors:  A J Hough; J W Hollifield; D L Page; W H Hartmann
Journal:  Am J Clin Pathol       Date:  1979-09       Impact factor: 2.493

4.  Discerning malignancy in adrenocortical tumors: are molecular markers useful?

Authors:  C Wachenfeld; F Beuschlein; O Zwermann; P Mora; M Fassnacht; B Allolio; M Reincke
Journal:  Eur J Endocrinol       Date:  2001-09       Impact factor: 6.664

Review 5.  Amplification of 9q34 in childhood adrenocortical tumors: a specific feature unrelated to ethnic origin or living conditions.

Authors:  B C Figueiredo; R C Ribeiro; G Zambetti; B Haddad; M D Pianovsky; R M Pereira; L DeLacerda; R Sandrini
Journal:  Braz J Med Biol Res       Date:  2000-10       Impact factor: 2.590

Review 6.  The role of the insulin-like growth factor system in adrenocortical tumourigenesis.

Authors:  M M Weber; C Fottner; E Wolf
Journal:  Eur J Clin Invest       Date:  2000-12       Impact factor: 4.686

7.  Diagnosis and monitoring of therapy of the various enzymatic defects causing congenital adrenal hyperplasia by semiautomatic capillary gas-liquid chromatography.

Authors:  D Knorr; F Bidlingmaier; U Kuhnle
Journal:  Horm Res       Date:  1982 Jul-Aug

8.  The alpha subunit of inhibin in adrenal cortical neoplasia.

Authors:  T J Pelkey; H F Frierson; S E Mills; M H Stoler
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

9.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

10.  Comparison of adrenal cortical tumors in children and adults.

Authors:  P T Cagle; A J Hough; T J Pysher; D L Page; E H Johnson; R T Kirkland; J H Holcombe; E P Hawkins
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

View more
  5 in total

1.  Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent.

Authors:  Emilia M Pinto; Christopher Morton; Carlos Rodriguez-Galindo; Lisa McGregor; Andrew M Davidoff; Kimberly Mercer; Larisa V Debelenko; Catherine Billups; Raul C Ribeiro; Gerard P Zambetti
Journal:  Clin Cancer Res       Date:  2013-02-13       Impact factor: 12.531

Review 2.  Renal and adrenal tumours in children.

Authors:  Kieran McHugh
Journal:  Cancer Imaging       Date:  2007-03-05       Impact factor: 3.909

Review 3.  Pediatric genitourinary oncology.

Authors:  Francisco Tibor Dénes; Ricardo Jordão Duarte; Lílian Maria Cristófani; Roberto Iglesias Lopes
Journal:  Front Pediatr       Date:  2013-12-16       Impact factor: 3.418

4.  Functioning adrenocortical tumors in children-secretory behavior.

Authors:  Ali A Ghazi; Djafar Mofid; Mohamad Taghi Salehian; Alireza Amirbaigloo; Khandan Zare; Bahar Jafari; Farzaneh Rahimi
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-02-19

Review 5.  Ectopic virilising adrenocortical tumour in the spinal region in an 8 year-old boy: a case report and review of the literature.

Authors:  Agata Skórka; Elżbieta Moszczyńska; Karolina Kot; Marcin Roszkowski; Elżbieta Jurkiewicz; Wiesława Grajkowska; Maciej Pronicki; Olgierd Pilecki; Mieczysław Szalecki
Journal:  Ital J Pediatr       Date:  2015-09-02       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.